These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10973373)

  • 1. Our social contract to offer optimum percutaneous coronary intervention.
    Weintraub WS
    J Invasive Cardiol; 2000 Sep; 12(9):472-3. PubMed ID: 10973373
    [No Abstract]   [Full Text] [Related]  

  • 2. Accreditation of hospitals for percutaneous coronary intervention on the basis of volume or clinical outcome using MEDPAR data sets: effect on patient mortality, cost and treatment accessibility.
    Ellis SG; Dushman-Ellis SJ
    J Invasive Cardiol; 2000 Sep; 12(9):464-71. PubMed ID: 10973372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The volume-outcome relationship of percutaneous coronary intervention: can current procedure volume minimums be applied to a developing country?
    Lin HC; Lee HC; Chu CH
    Am Heart J; 2008 Mar; 155(3):547-52. PubMed ID: 18294495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001.
    Kansagra SM; Curtis LH; Anstrom KJ; Schulman KA
    Am J Cardiol; 2007 Feb; 99(3):339-43. PubMed ID: 17261394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing quality and outcomes for percutaneous coronary intervention: choosing statistical models, outcomes, time periods, and patient populations.
    Hannan EL; Wu C
    Am Heart J; 2003 Apr; 145(4):571-4. PubMed ID: 12679749
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
    Maier W; Windecker S; Boersma E; Meier B
    Eur Heart J; 2001 Sep; 22(18):1733-40. PubMed ID: 11511123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct and indirect treatment cost of patient with ischaemic heart disease].
    Maciag A; Wysocki MJ; Bak MI
    Przegl Epidemiol; 2008; 62(3):669-76. PubMed ID: 19108532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of care in myocardial revascularization procedures.
    Eldar R
    Croat Med J; 2002 Dec; 43(6):727-30. PubMed ID: 12476484
    [No Abstract]   [Full Text] [Related]  

  • 10. It is never too late for PCI: To relieve medically refractory myocardial ischemia.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):455-6. PubMed ID: 19235234
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-term outcomes after percutaneous coronary intervention: effects of stenting and institutional volume shifts.
    Watanabe CT; Maynard C; Ritchie JL
    Am Heart J; 2002 Aug; 144(2):310-4. PubMed ID: 12177650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and in-hospital mortality associated with two cardiac procedures, by sex and age: national trends, 1990-2004.
    Holmes JS; Kozak LJ; Owings MF
    Health Aff (Millwood); 2007; 26(1):169-77. PubMed ID: 17211026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina.
    Ramanathan KB; Weiman DS; Sacks J; Morrison DA; Sedlis S; Sethi G; Henderson WG
    Ann Thorac Surg; 2005 Oct; 80(4):1340-6. PubMed ID: 16181866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking the measure of clinical care.
    O'Connor GT
    Can J Cardiol; 2003 Jun; 19(7):771-3. PubMed ID: 12813609
    [No Abstract]   [Full Text] [Related]  

  • 15. Angioplasty: practice makes "better".
    Harv Heart Lett; 1999 Jun; 9(10):3-4. PubMed ID: 10233787
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjusting for patient differences in predicting hospital mortality for percutaneous coronary interventions in the Clinical Outcomes Assessment Program.
    Maynard C; Goss JR; Malenka DJ; Reisman M;
    Am Heart J; 2003 Apr; 145(4):658-64. PubMed ID: 12679762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multistate comparison of patient characteristics, outcomes, and treatment practices in acute myocardial infarction.
    Saleh SS; Hannan EL; Ting L
    Am J Cardiol; 2005 Nov; 96(9):1190-6. PubMed ID: 16253580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Porto I; Van Gaal W; Banning A
    Eur Heart J; 2005 Oct; 26(20):2206; author reply 2206-7. PubMed ID: 16087650
    [No Abstract]   [Full Text] [Related]  

  • 20. Procedure rates and outcomes of coronary revascularization procedures in California and New York.
    Carey JS; Danielsen B; Gold JP; Rossiter SJ
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1276-82. PubMed ID: 15942567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.